As of 2026-03-19, the Relative Valuation of Oric Pharmaceuticals Inc (ORIC) is (29.19) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.07 USD, the upside of Oric Pharmaceuticals Inc based on Relative Valuation is -341.8%.
The range of the Relative Valuation is (26.37) - (30.83) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.4x - 26.1x | 23.2x |
| Forward P/E multiples | 20.4x - 23.9x | 22.1x |
| Fair Price | (26.37) - (30.83) | (29.19) |
| Upside | -318.5% - -355.4% | -341.8% |
| Date | P/E |
| 2026-03-13 | -9.22 |
| 2026-03-12 | -9.12 |
| 2026-03-11 | -9.76 |
| 2026-03-10 | -9.76 |
| 2026-03-09 | -9.03 |
| 2026-03-06 | -10.63 |
| 2026-03-05 | -10.74 |
| 2026-03-04 | -10.47 |
| 2026-03-03 | -10.47 |
| 2026-03-02 | -10.76 |
| 2026-02-27 | -10.43 |
| 2026-02-26 | -10.46 |
| 2026-02-25 | -10.39 |
| 2026-02-24 | -10.40 |
| 2026-02-23 | -9.08 |
| 2026-02-20 | -8.61 |
| 2026-02-19 | -8.78 |
| 2026-02-18 | -8.40 |
| 2026-02-17 | -7.82 |
| 2026-02-13 | -7.74 |
| 2026-02-12 | -7.94 |
| 2026-02-11 | -7.91 |
| 2026-02-10 | -8.19 |
| 2026-02-09 | -8.30 |
| 2026-02-06 | -8.08 |
| 2026-02-05 | -7.72 |
| 2026-02-04 | -8.22 |
| 2026-02-03 | -8.53 |
| 2026-02-02 | -8.65 |
| 2026-01-30 | -7.95 |
| 2026-01-29 | -8.34 |
| 2026-01-28 | -8.51 |
| 2026-01-27 | -9.39 |
| 2026-01-26 | -9.50 |
| 2026-01-23 | -9.29 |
| 2026-01-22 | -9.34 |
| 2026-01-21 | -9.50 |
| 2026-01-20 | -9.01 |
| 2026-01-16 | -9.40 |
| 2026-01-15 | -8.93 |
| 2026-01-14 | -8.72 |
| 2026-01-13 | -7.86 |
| 2026-01-12 | -7.09 |
| 2026-01-09 | -7.09 |
| 2026-01-08 | -6.55 |
| 2026-01-07 | -6.73 |
| 2026-01-06 | -6.31 |
| 2026-01-05 | -6.32 |
| 2026-01-02 | -6.33 |
| 2025-12-31 | -6.34 |